Akoya Biosciences Inc (AKYA)
2.79
-0.11
(-3.79%)
USD |
NASDAQ |
May 15, 16:00
2.81
+0.02
(+0.72%)
After-Hours: 20:00
Akoya Biosciences Cash from Financing (Quarterly): 11.08M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.08M |
| September 30, 2023 | -0.141M |
| June 30, 2023 | 46.33M |
| March 31, 2023 | -0.419M |
| December 31, 2022 | 10.27M |
| September 30, 2022 | 9.86M |
| June 30, 2022 | 8.667M |
| March 31, 2022 | -0.071M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.149M |
| September 30, 2021 | -0.044M |
| June 30, 2021 | 136.93M |
| March 31, 2021 | -0.004M |
| December 31, 2020 | 5.687M |
| September 30, 2020 | 0.04M |
| June 30, 2020 | 2.419M |
| March 31, 2020 | -2.66M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.66M
Minimum
Mar 2020
136.93M
Maximum
Jun 2021
14.26M
Average
1.284M
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | 151.70M |
| Azenta Inc | -74.07M |
| Harvard Bioscience Inc | -1.055M |
| Bionano Genomics Inc | -21.62M |
| Singular Genomics Systems Inc | 0.072M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.584M |
| Cash from Investing (Quarterly) | -0.594M |
| Free Cash Flow | -54.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1244 |
| Free Cash Flow to Equity (Quarterly) | -17.61M |
| Free Cash Flow to Firm (Quarterly) | -4.801M |
| Free Cash Flow Yield | -44.03% |